Small nuclear ribonucleoprotein polypeptide G pseudogene 13 (SNRPGP13)

SNRPGP13 is classified as a pseudogene of the small nuclear ribonucleoprotein polypeptide G (SNRPG). Pseudogenes are genomic DNA sequences similar to normal genes but are usually non-functional; they are typically not transcribed into protein or do not produce a functional protein. SNRPG (not SNRPGP13) is one of the seven core Sm proteins that are critical for spliceosome formation, mRNA splicing, and various cellular processes such as cell proliferation and apoptosis[1][3]. However, pseudogenes like SNRPGP13 lack these functions and are not considered valid molecular targets for therapy or drug development. SNRPG encodes a functional component of the spliceosomal small nuclear ribonucleoproteins essential for pre-mRNA splicing[1][3]. It may play roles in oncogenesis and cell cycle regulation and has been implicated as a poor prognostic marker in some cancers[1][3]. SNRPGP13, denoted by the "P" and number, designates a pseudogene of SNRPG—a gene copy that does not encode a functional product. Pseudogenes are generally not transcribed, lack protein-coding potential, and do not participate directly in canonical molecular, cellular, or disease processes attributed to their parent genes. Thus, SNRPGP13 is not a therapeutic target. No aliases, drugs, mechanisms, biomarkers, or safety concerns are applicable to SNRPGP13 specifically, as it does not produce a functional molecule. Summary of key points: - SNRPGP13 is a pseudogene, not a protein or receptor. - It is not a therapeutic target. - All biological function, disease, or drug association information pertains to the parent gene SNRPG, not this pseudogene. - Entry is considered "incorrect" as a drug target, since pseudogenes are not valid drug targets.

Other names

SNRPGP13Small nuclear ribonucleoprotein polypeptide G pseudogene 13